DILLON & ASSOCIATES INC - Q1 2022 holdings

$527 Million is the total value of DILLON & ASSOCIATES INC's 78 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .

 Value Shares↓ Weighting
NVS  Novartis AG ADS$744,000
+1.2%
8,4490.0%0.14%
+10.2%
UNH  UnitedHealth Group Inc.$605,000
+1.5%
1,1870.0%0.12%
+10.6%
TGT  Target Corp.$567,000
-8.1%
2,6730.0%0.11%0.0%
K  Kellogg$539,0000.0%8,4200.0%0.10%
+8.5%
EMR  Emerson Electric$378,000
+5.3%
3,8570.0%0.07%
+14.3%
CSCO  Cisco Systems$342,000
-11.2%
6,1100.0%0.06%
-3.0%
BMY  Bristol-Myers Squibb$289,000
+18.0%
3,9550.0%0.06%
+27.9%
COF  Capital One Fin'l$216,000
-9.6%
1,6500.0%0.04%
-2.4%
RMTI  Rockwell Medical Tech Inc$5,0000.0%11,4940.0%0.00%0.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-06
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Apple, Inc.42Q3 202311.9%
Stryker42Q3 20236.3%
Visa Inc.42Q3 20236.5%
Abbott Labs42Q3 20235.7%
Automatic Data Processing42Q3 20234.8%
PepsiCo42Q3 20234.9%
Colgate-Palmolive42Q3 20235.9%
Paychex42Q3 20234.3%
Air Products42Q3 20233.7%
Lowe's42Q3 20233.9%

View DILLON & ASSOCIATES INC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-30
13F-HR2024-02-08
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR/A2023-05-02
13F-HR2023-05-01
13F-HR2023-02-06
13F-HR2022-11-08
13F-HR2022-07-26
13F-HR2022-05-06

View DILLON & ASSOCIATES INC's complete filings history.

Compare quarters

Export DILLON & ASSOCIATES INC's holdings